CMAC 2001; 3(3) | CMAC

CMAC 2001; 3(3)

The present literature review is devoted to the one of the actual problems in the intensive care units – to the nosocomial pneumonia …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):198-208
PDF

One hundred thirty six patients in whom HВsAg and anti-HCV have been simultaneously detected were investigated. In all cases the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):209-214
PDF

Amebiasis is a parasitic human disease caused by pathogenic strains of Entamoeba histolytica, and is one of the most important problems …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):215-222
PDF

β-Lactamases are represented by extensive range of genetically and functionally different enzymes that are able to destroy β-lactams …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):223-242
PDF

Moxifloxacin – new broad spectrum 8-methoxyquinolon with high activity against Gram(+) and Gram(-) microorganisms as well as against …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):243-259
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):260-265
PDF

Identification of Listeria monocytogenes in clinical specimens is often complicated because of morphological and biochemical properties …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):266-273
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):274-279
PDF